🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

186 results for “Air” Clear

  1. TD-4208

    Theravance Biopharma Ireland Umited

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  2. Tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  3. Tebipenem pivoxil hydrobromide (TBPM-PI-HBr)

    Spero Therapeutics

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  4. Teduglutide

    Takeda Pharmaceuticals International AG

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  5. Telotristat Ethyl

    LEXICON PHARMACEUTICALS, INC.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  6. VIR-2218

    Vir Biotechnology

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  7. VIR-2218

    Vir Biotechnology

    Hepatic Impairment

    phase 1 small molecule active

    1 trial

  8. Vadadustat

    Akebia Europe Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  9. Visual Sputum Suctioning System

    First Tracks Biotherapeutics

    Ineffective Airway Clearance

    phase 1 other active

    1 trial

  10. Vortioxetine

    Takeda Pharmaceuticals International AG

    Severe Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  11. Yimitasvir Phosphate

    Sunshine Biopharma

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  12. Yimitasvir Phosphate Capsule

    Sunshine Biopharma

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  13. belapectin

    GALECTIN THERAPEUTICS INC

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  14. lofexidine HCl

    BRIGHT MINDS BIOSCIENCES INC.

    Renally Impaired Subjects

    phase 1 small molecule completed

    1 trial

  15. lumacaftor 200 mg q12h + ivacaftor 250 mg q12h

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  16. questionnaires

    Cardiff Oncology

    Anxiety

    phase 1 other active

    1 trial

  17. sotagliflozin

    LEXICON PHARMACEUTICALS, INC.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  18. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  19. ​​AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors ​

    Amgen Technology (Ireland) UC

    microsatellite instability high/mismatch repair deficient (MSI-H/dMMR) solid tumors

    phase 1 other active

    1 trial

  20. AO-128

    Takeda Pharmaceuticals International AG

    Impaired Glucose Tolerance (IGT)

    approved small molecule completed

    1 trial

  21. Advair Diskus100/50 µg

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  22. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Pharma Mar S.A.

    Asthma

    approved small molecule active

    1 trial

  23. AirDuo Digihaler

    Teva Pharma GmbH

    Asthma

    approved other completed

    1 trial

  24. Calquence 100 mg film-coated tablets, Calquence 100 mg film-coated tablets

    AstraZeneca AB

    Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources